The DOI matches its Crossref record; 46 of the 47 references it cites were found in a registry or an index; none of the 7 sources its claims cite is checked for support yet.
FIH-1: a novel protein that interacts with HIF-1α and VHL to mediate repression of HIF-1 transcriptional activity
Open accessAbstract
Hypoxia-inducible factor 1 (HIF-1) is a master regulator of oxygen homeostasis that controls angiogenesis, erythropoiesis, and glycolysis via transcriptional activation of target genes under hypoxic conditions. O 2 -dependent binding of the von Hippel-Lindau (VHL) tumor suppressor protein targets the HIF-1α subunit for ubiquitination and proteasomal degradation. The activity of the HIF-1α transactivation domains is also O 2 regulated by a previously undefined mechanism. Here, we report the identification of factor inhibiting HIF-1 (FIH-1), a protein that binds to HIF-1α and inhibits its transactivation function. In addition, we demonstrate that FIH-1 binds to VHL and that VHL also functions as a transcriptional corepressor that inhibits HIF-1α transactivation function by recruiting histone deacetylases. Involvement of VHL in association with FIH-1 provides a unifying mechanism for the modulation of HIF-1α protein stabilization and transcriptional activation in response to changes in cellular O 2 concentration.
Overview
AI snapshot
Written from the paper’s full text.
TL;DR
The paper identifies FIH-1, a 349-amino-acid protein that binds HIF-1α and VHL and represses HIF-1 transcriptional activity. It proposes that VHL and FIH-1 act as corepressors by recruiting histone deacetylases, unifying O₂-dependent control of HIF-1α stability and transactivation.
Key findings
- A yeast two-hybrid screen of 2 × 10⁶ transformants identified FIH-1 from a 2.98-kb human brain cDNA encoding a 349-amino-acid protein; the FIH1 gene maps to chromosome 10q24 and consists of eight exons and seven introns spanning 14 kb.
- FIH-1 binds HIF-1α residues 531–826, with optimal binding requiring TAD-C; residues 757–826 are sufficient, whereas TAD-N (531–575) and TAD-C alone (786–826) did not bind.
- FIH-1 inhibits HIF-1α transactivation in 293 and Hep3B reporter assays at 1% O₂; antisense FIH-1 increases reporter expression, and FIH-1 inhibits GalA (HIF-1α 531–826) under both 20% and 1% O₂.
- FIH-1 binds VHL at a distinct site (VHL residues 1–155 sufficient for FIH-1 binding; 1–213 required for efficient HIF-1α binding), and VHL plus FIH-1 cooperatively repress GalL (HIF-1α 531–575); VHL binds HDAC-1, HDAC-2, and HDAC-3 and recruits HDACs to HIF-1α.
Methods
- Yeast two-hybrid assay using GAL4 DBD–HIF-1α(576–826) bait and a human brain cDNA prey library; 2 × 10⁶ transformants screened for histidine auxotrophy and α-galactosidase expression.
- In vitro GST pull-down assays with ³⁵S-labeled HIF-1α, FIH-1, VHL, and HDAC proteins; some GST-HIF-1α fusions were preincubated with reticulocyte lysate to induce proline hydroxylation.
- Transient transfection of HEK293 and Hep3B cells with p2.1 or pG5ElbLuc reporters and GAL4–HIF-1α fusion constructs, exposed to 20% or 1% O₂; immunoprecipitation and immunoblot assays for protein interactions.
Limitations
- Stated: coimmunoprecipitation of FIH-1 and HIF-1α was detected in cells overexpressing these proteins, so no conclusion can be drawn as to whether the interaction is regulated by cellular O₂ concentration; VHL expression may have been limiting, and no interaction of VHL with FIH-1 or HIF-1α could be demonstrated under those conditions.
- Stated: whether O₂-dependent interaction of HIF-1α and VHL is required for recruitment of FIH-1 remains unanswered; an alternative but not mutually exclusive hypothesis is that FIH-1 and VHL recruit distinct HDAC complexes.
- Evident: many interaction and repression conclusions rely on overexpression and in vitro binding assays; FIH-1’s weaker HDAC binding and the possibilities that it interacts with HDAC-4–7, another corepressor, or possesses intrinsic HDAC activity are speculative and not demonstrated.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
0 of 7 cited sources checked · 0 supported · 0 flagged
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Interaction of VHL and FIH-1 with histone deacetylases.”
§ FIH-1: a novel protein that interacts with HIF-1␣ and VHL to mediate repression of HIF-1 transcriptional activity > Immunoprecipitation assay
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Functional interaction of FIH-1 and VHL to repress HIF-1␣ transactivation domain function.”
§ FIH-1: a novel protein that interacts with HIF-1␣ and VHL to mediate repression of HIF-1 transcriptional activity > Immunoprecipitation assay
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Effect of FIH-1 on HIF-1-mediated reporter gene transcription.”
§ FIH-1: a novel protein that interacts with HIF-1␣ and VHL to mediate repression of HIF-1 transcriptional activity > Immunoprecipitation assay
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Interaction of FIH-1, HIF-1␣, and VHL in vitro.”
§ FIH-1: a novel protein that interacts with HIF-1␣ and VHL to mediate repression of HIF-1 transcriptional activity > Immunoprecipitation assay
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Identification of FIH-1 by yeast two-hybrid screen.”
§ FIH-1: a novel protein that interacts with HIF-1␣ and VHL to mediate repression of HIF-1 transcriptional activity > Immunoprecipitation assay
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- Rests on an assumption: The physical interaction of bait and prey proteins within yeast cells functionally reconstitutes an active GAL4 transcription factor, resulting in expression of genes containing upstream GAL4-binding sites that mediate histidine auxotrophy and α-gal expression.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Interaction of FIH-1 and HIF-1␣ in human cells.”
§ FIH-1: a novel protein that interacts with HIF-1␣ and VHL to mediate repression of HIF-1 transcriptional activity > Immunoprecipitation assay
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Localization of HIF-1␣ residues interacting with FIH-1.”
§ FIH-1: a novel protein that interacts with HIF-1␣ and VHL to mediate repression of HIF-1 transcriptional activity > Immunoprecipitation assay
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“binding of VHL to the intact HIF-1␣ regulatory domain (residues 531-826) does not require preincubation of HIF-1␣ with cellular lysate (as a source of putative prolyl hydroxylase activity; Fig. 4D)”
§ FIH-1: a novel protein that interacts with HIF-1␣ and VHL to mediate repression of HIF-1 transcriptional activity > Discussion
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“TBLASTN searches revealed similarity of FIH-1 to the rat PASS1 protein (GenBank accession no.AF168362.1),proteins encoded by human ESTs FLJ13798 (AK023860.1)and FLJ20656 (AK000663.1),as well as to open reading frames in Caenorhabditis briggsae (AC084551.1)and Drosophila melanogaster (AE003469.2,AE003537.2) genomic DNA, thus defining a family of related proteins that has been conserved through inve”
§ FIH-1: a novel protein that interacts with HIF-1␣ and VHL to mediate repression of HIF-1 transcriptional activity > Identification of FIH-1 in a screen for HIF-1␣-interacting proteins
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesNone of the sources cited for this claim have been checked yet.
In the paper
“Thus, FIH-1 loss-of-function may contribute to increased HIF-1-mediated transactivation of downstream target genes such as VEGF in gliomas and other human cancers (Semenza 2000; Zagzag et al. 2000).”
§ FIH-1: a novel protein that interacts with HIF-1␣ and VHL to mediate repression of HIF-1 transcriptional activity > Discussion
What the sources say
- Not checked yetcites Semenza 2000
- Not checked yetcites Zagzag et al. 2000
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes
- It may state two separate claims as one. 4
- Probably not a substantial claim. 3
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Nucleotide sequence analysis revealed that the prey vector contained a 2.98-kb human cDNA encoding a 349-amino-acid protein that was subsequently designated FIH-1 (GenBank accession no.AF395830).”
§ FIH-1: a novel protein that interacts with HIF-1␣ and VHL to mediate repression of HIF-1 transcriptional activity > Identification of FIH-1 in a screen for HIF-1␣-interacting proteins
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Analysis of genomic DNA sequences deposited in Gen-Bank revealed that the FIH1 gene is present in contig NT 008635, which is mapped to human chromosome 10q24, and consists of eight exons and seven introns that span 14 kb of DNA.”
§ FIH-1: a novel protein that interacts with HIF-1␣ and VHL to mediate repression of HIF-1 transcriptional activity > Identification of FIH-1 in a screen for HIF-1␣-interacting proteins
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neither FIH-1 nor VHL alone inhibited GalL-mediated transactivation, whereas the combination of FIH-1 and VHL resulted in significant transcriptional repression.”
§ FIH-1: a novel protein that interacts with HIF-1␣ and VHL to mediate repression of HIF-1 transcriptional activity > Inhibition of HIF-1␣ transactivation domain function by VHL and FIH-1 in human cells
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“EST data indicate that FIH-1 is expressed in multiple cell types derived from adrenal, bladder, brain (adult and fetal), breast, colon, embryo, foreskin, germ cell, heart, kidney, lung, lymph, marrow, muscle, nerve, ovary, parathyroid, prostate, skin, testis, tonsil, and uterus.”
§ FIH-1: a novel protein that interacts with HIF-1␣ and VHL to mediate repression of HIF-1 transcriptional activity > Identification of FIH-1 in a screen for HIF-1␣-interacting proteins
Strength:hedged· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Negative regulation of HIF-1␣ protein stability and transcriptional activity under nonhypoxic conditions mediated by VHL and FIH-1.”
§ FIH-1: a novel protein that interacts with HIF-1␣ and VHL to mediate repression of HIF-1 transcriptional activity > Immunoprecipitation assay
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
- Rests on an assumption: Elongins B and C and cullin 2 are required for E3 ubiquitin-protein ligase activity, whereas HDACs repress transactivation.
In the paper
“Residues 576-785 comprise an inhibitory domain the deletion of which increases transactivation domain function especially under nonhypoxic conditions (Jiang et al. 1997).”
§ FIH-1: a novel protein that interacts with HIF-1␣ and VHL to mediate repression of HIF-1 transcriptional activity > Abstract
What the sources say
- Not checked yetcites Jiang et al. 1997
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
The paper relies on this without support.
HIF-1 activity is induced by hypoxia in all cell types.
“Because HIF-1 activity is induced by hypoxia in all cell types, the interaction of HIF-1 with other proteins is likely to play a major role in determining its biological activity.”
The paper relies on this without support.
HIF-1α contains basic helix-loop-helix (bHLH) and PAS domains required for dimerization and DNA binding, a proline/serine/threonine-rich protein stabilization domain (PSTD), two transactivation domains (TAD-N and TAD-C), and an inhibitory domain (ID) that negatively regulates transactivation domain function under nonhypoxic conditions.
“HIF-1␣ contains basic helix-loop-helix (bHLH) and PAS domains that are required for dimerization and DNA binding, a proline/serine/threonine-rich protein stabilization domain (PSTD), two transactivation domains (TAD-N and TAD-C), and an inhibitory domain (ID) that negatively regulates transactivation domain function under nonhypoxic conditions.”
The paper relies on this without support.
Elongins B and C and cullin 2 are required for E3 ubiquitin-protein ligase activity, whereas HDACs repress transactivation.
“Elongins B and C and cullin 2 are required for E3 ubiquitin-protein ligase activity, whereas HDACs repress transactivation.”
The paper relies on this without support.
The physical interaction of bait and prey proteins within yeast cells functionally reconstitutes an active GAL4 transcription factor, resulting in expression of genes containing upstream GAL4-binding sites that mediate histidine auxotrophy and α-gal expression.
“The physical interaction of the bait and prey proteins within yeast cells functionally reconstitutes an active GAL4 transcription factor, resulting in the expression of genes that contain upstream GAL4-binding sites and mediate histidine auxotrophy (his + ) and ␣-gal expression.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“although it remains capable of binding the CAD under these conditions (Mahon et al. 2001).”
From FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor (2002) · cites this paper as Mahon et al. 2001
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“HIF transcriptional activity is also regulated by a second oxygen-sensitive hydroxylation event mediated by factor inhibiting HIF-1 (FIH-1) (Mahon et al., 2001;Lando et al., 2002).”
From Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer (2016) · cites this paper as Mahon et al., 2001
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This mechanism attenuates HIF transcriptional activity during early reoxygenation, acting as a buffer that limits the excessive metabolic activation and oxidative stress during the transition from hypoxia to normoxia”
From HIF inhibition: Current strategies and clinical challenges (2026) · cites this paper as [52]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“FIH-1 functions at lower oxygen tensions than PHDs and hydroxylates a single asparagine residue within the C-terminal transactivation domain of HIF-1α, consequently limiting engagement of transcriptional co-activator complexes [52,53]”
From HIF inhibition: Current strategies and clinical challenges (2026) · cites this paper as [52]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Although the two modes of regulation can be apparently uncoupled from each other through the construction of chimeras containing either the ODD or the CAD, the machinery regulating the two appears to be linked (Mahon et al. 2001).”
From FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor (2002) · cites this paper as Mahon et al. 2001
The cited source says what the claim attributes to it.
In the citing paper
“In vitro binding studies suggest that FIH-1 and pVHL interact and may be part of a larger complex that represses HIF by multiple mechanisms under normoxic conditions (Mahon et al. 2001)”
From FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor (2002) · cites this paper as Mahon et al. 2001
In the citing paper
“Hif-1α is also hydroxylated in an oxygen-dependent reaction on a highly conserved asparagine residue by FIH-1 (Factor inhibiting HIF-1), which blocks the ability of Hif-1α to recruit transcriptional coactivators such as p300/CBP, in turn limiting transcriptional activation by Hif-1α under non-hypoxic conditions [45, 46].”
From Hypoxia and hypoxia-inducible factors as regulators of T cell development, differentiation, and function (2013) · cites this paper as [45]
Citations
Cites
Wang, G. L., Jiang, B. H., Rue, E. A., & Semenza, G. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5510 · Cited by 6,212
Self-citationA novel genetic system to detect protein–protein interactions
Fields, S., & Song, O.-K. (1989) · Nature · doi:10.1038/340245a0 · Cited by 6,152
Jaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735
Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis
Carmeliet, P., Dor, Y., Herbert, J.-M., Fukumura, D., Brusselmans, K., Dewerchin, M., Neeman, M., Bono, F., Abramovitch, R., Maxwell, P., et al. (1998) · Nature · doi:10.1038/28867 · Cited by 2,502
Hoffman, C. S., & Winston, F. (1987) · Gene · doi:10.1016/0378-1119(87)90131-4 · Cited by 2,492
Cellular and developmental control of O 2 homeostasis by hypoxia-inducible factor 1α
Iyer, N. V., Kotch, L. E., Agani, F., Leung, S. W., Laughner, E., Wenger, R. H., Gassmann, M., Gearhart, J. D., Lawler, A. M., Yu, A. Y., et al. (1998) · Genes & Development · doi:10.1101/gad.12.2.149 · Cited by 2,476
Self-citationHuang, L. E., Gu, J., Schau, M., & Bunn, H. F. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.7987 · Cited by 2,113
Purification and Characterization of Hypoxia-inducible Factor 1
Wang, G. L., & Semenza, G. L. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.3.1230 · Cited by 2,094
Self-citation
Flagged first, then by citations
1 of the 47 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 801–900 of 1,002
Factor‐inhibiting HIF‐1 (FIH‐1) is required for human vascular endothelial cell survival
Kiriakidis, S., Henze, A., Kruszynska‐Ziaja, I., Skobridis, K., Theodorou, V., Paleolog, E. M., & Mazzone, M. (2015) · The FASEB Journal · doi:10.1096/fj.14-252379 · Cited by 32
Hypoxia and Metastasis in Breast Cancer
Rundqvist, H., & Johnson, R. S. (2010) · Current topics in microbiology and immunology · doi:10.1007/82_2010_77 · Cited by 33
The interplay between the cellular hypoxic response and Notch signaling
Landor, S. K.-J., & Lendahl, U. (2017) · Experimental Cell Research · doi:10.1016/j.yexcr.2017.04.030 · Cited by 33
Advances in autologous chondrocyte implantation and related techniques for cartilage repair.
Foldager, C. B. (2013) · PubMed · Cited by 30
Fundamental roles for hypoxia signalling in adipose tissue metabolism and inflammation in obesity
Michailidou, Z. (2019) · Current Opinion in Physiology · doi:10.1016/j.cophys.2019.09.005 · Cited by 30
HIF hydroxylase inhibitors decrease cellular oxygen consumption depending on their selectivity
Sulser, P., Pickel, C., Günter, J., Leissing, T. M., Crean, D., Schofield, C. J., Wenger, R. H., & Scholz, C. C. (2019) · The FASEB Journal · doi:10.1096/fj.201902240r · Cited by 30
CITED2 and the modulation of the hypoxic response in cancer
Fernandes, M. T., Calado, S. M., Mendes-Silva, L., & Bragança, J. (2020) · World Journal of Clinical Oncology · doi:10.5306/wjco.v11.i5.260 · Cited by 30
Oxygen gradient and tumor heterogeneity: The chronicle of a toxic relationship
Pandkar, M. R., Dhamdhere, S. G., & Shukla, S. (2021) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2021.188553 · Cited by 33
Kim, J.-W., An, H., Yeo, H., Jeong, Y., Lee, H., Lee, J., Nam, K.-S., Lee, J., Shin, D.-E., & Lee, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111355 · Cited by 30
Pierre, C. C., Longo, J., Bassey-Archibong, B. I., Hallett, R. M., Milosavljevic, S., Beatty, L., Hassell, J. A., & Daniel, J. M. (2015) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2015.10.018 · Cited by 30
Structure of the JmjC-domain-containing protein JMJD5
Wang, H., Zhou, X., Wu, M., Wang, C., Zhang, X., Tao, Y., Chen, N., & Zang, J. (2013) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444913016600 · Cited by 30
The Antioxidant Quercetin Inhibits Cellular Proliferation via HIF-1-Dependent Induction of p21WAF
Bach, A., Bender–Sigel, J., Schrenk, D., Flügel, D., & Kietzmann, T. (2009) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.3000 · Cited by 30
Kopp, R., Schwerte, T., Egg, M., Sandbichler, A. M., Egger, B., & Pelster, B. (2010) · Physiological Genomics · doi:10.1152/physiolgenomics.00052.2010 · Cited by 30
A Zebrafish Model for VHL and Hypoxia Signaling
van Rooijen, E., Santhakumar, K., Logister, I., Voest, E. E., Schulte‐Merker, S., Giles, R. H., & Eeden, F. V. (2011) · Methods in cell biology · doi:10.1016/b978-0-12-381320-6.00007-2 · Cited by 31
Grow₂: the HIF system, energy homeostasis and the cell cycle.
Moniz, S., Biddlestone, J., & Rocha, S. (2014) · PubMed · doi:10.14670/hh-29.10.589 · Cited by 30
Chen, H., Li, J., Liang, S., Lin, B., Peng, Q., Zhao, P., Cui, J., & Rao, Y. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.4049 · Cited by 30
Takabuchi, S., Hirota, K., Nishi, K., Oda, S., Oda, T., Shingu, K., Takabayashi, A., Adachi, T., Semenza, G. L., & Fukuda, K. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.09.064 · Cited by 30
Self-citationWillam, C., Nicholls, L. G., Ratcliffe, P. J., Pugh, C. W., & Maxwell, P. H. (2004) · Advances in Enzyme Regulation · doi:10.1016/j.advenzreg.2003.11.017 · Cited by 31
Revisiting the role of hypoxia-inducible factors in pulmonary hypertension
Shimoda, L. A., Yun, X., & Sikka, G. (2019) · Current Opinion in Physiology · doi:10.1016/j.cophys.2018.12.003 · Cited by 29
Multi-Omic Meta-Analysis of Transcriptomes and the Bibliome Uncovers Novel Hypoxia-Inducible Genes
Ono, Y., & Bono, H. U. (2021) · Biomedicines · doi:10.3390/biomedicines9050582 · Cited by 29
Wilkins, S. E., Karttunen, S., Hampton‐Smith, R. J., Murchland, I., Chapman‐Smith, A., & Peet, D. J. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.294678 · Cited by 29
Linke, S., Hampton‐Smith, R. J., & Peet, D. J. (2007) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(07)35004-0 · Cited by 29
van den Beucken, T., Magagnin, M. G., Savelkouls, K. G. M., Lambin, P., Koritzinsky, M., & Wouters, B. G. (2007) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2007.04.026 · Cited by 29
Bell, E. L., Klimova, T. A., & Chandel, N. S. (2007) · Antioxidants and Redox Signaling · doi:10.1089/ars.2007.1655 · Cited by 29
Longitudinal dynamics of the tumor hypoxia response: From enzyme activity to biological phenotype
Lee, S. C.-E. S., Pyo, A. H. A., & Koritzinsky, M. (2023) · Science Advances · doi:10.1126/sciadv.adj6409 · Cited by 28
A novel regulation of VEGF expression by HIF‐1α and STAT3 in HDM2 transfected prostate cancer cells
Rathinavelu, A., Narasimhan, M., & Muthumani, P. (2011) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2011.01472.x · Cited by 28
Enigmas of IDH mutations in hematology/oncology
Heuser, M., Cruz, M. M. A., Goparaju, R., & Chaturvedi, A. (2015) · Experimental Hematology · doi:10.1016/j.exphem.2015.05.005 · Cited by 28
Hypoxia-Inducible Factors Regulate Osteoclasts in Health and Disease
Meng, X., Wielockx, B., Rauner, M., & Bözec, A. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.658893 · Cited by 28
Yu, Y.-C., Yang, F., Yu, Q., Liu, S., Wu, C., Su, K., Yang, L., Bao, X., Li, Z., Li, X., et al. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c01479 · Cited by 28
Engineering nanomedicines to inhibit hypoxia-inducible Factor-1 for cancer therapy
Zhang, X., He, C., & Xiang, G. (2022) · Cancer Letters · doi:10.1016/j.canlet.2022.01.012 · Cited by 28
Mirzaei, S., Ranjbar, B., Tackallou, S. H., & Aref, A. R. (2023) · Pathology - Research and Practice · doi:10.1016/j.prp.2023.154676 · Cited by 28
Loss of the SIN3 transcriptional corepressor results in aberrant mitochondrial function
Barnes, V. L., Strunk, B. S., Lee, I., Hüttemann, M., & Pile, L. A. (2010) · BMC Biochemistry · doi:10.1186/1471-2091-11-26 · Cited by 28
Webb, J. D., Murányi, A., Pugh, C. W., Ratcliffe, P. J., & Coleman, M. L. (2009) · Biochemical Journal · doi:10.1042/bj20081905 · Cited by 28
HIF prolyl hydroxylase inhibition augments dopamine release in the rat brain in vivo
Witten, L. M., Sager, T. N., Thirstrup, K., Johansen, J. L., Larsen, D. B., Montezinho, L. P., & Mørk, A. (2009) · Journal of Neuroscience Research · doi:10.1002/jnr.21988 · Cited by 28
Hypoxia in Skin Cancer: Molecular Basis and Clinical Implications
Jeon, S., Jeon, M., Choi, S., Yoo, S., Park, S.-H., Lee, M., & Kim, I. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054430 · Cited by 28
Hypoxia-driven angiogenesis and metabolic reprogramming in vascular tumors
Liu, L., Yu, J., Liu, Y., Xie, L., Hu, F., & Liu, H. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1572909 · Cited by 29
Kaluz, Š., Kaluzová, M., & Stanbridge, E. J. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21644 · Cited by 27
Wang, Q., Shen, W.-L., Liu, C., Mu, D.-L., Wu, X., Guo, N.-G., & Zhu, J. (2017) · Chemosphere · doi:10.1016/j.chemosphere.2017.06.043 · Cited by 27
Skin Rejuvenation through HIF-1α Modulation
Pagani, A., Aitzetmüller, M. M., Brett, E. A., König, V., Wenny, R., Thor, D., Radtke, C., Huemer, G. M., Machens, H., & Duscher, D. (2017) · Plastic & Reconstructive Surgery · doi:10.1097/prs.0000000000004256 · Cited by 28
Hypoxia and the Receptor for Advanced Glycation End Products (RAGE) Signaling in Cancer
Taneja, S., Vetter, S. W., & Leclerc, E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158153 · Cited by 28
Role of Hypoxia in the Interferon Response
Arnaiz, E., & Harris, A. L. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.821816 · Cited by 28
Melnik, B. C., & Schmitz, G. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911503 · Cited by 27
Karagiota, A., Kanoura, A., Paraskeva, E., Simos, G., & Chachami, G. (2022) · FEBS Journal · doi:10.1111/febs.16694 · Cited by 30
Ting, K. K. Y., Yu, P., Dow, R., Floro, E. J., Ibrahim, H. M., Scipione, C. A., Hyduk, S. J., Polenz, C. K., Zaslaver, O., Karmaus, P. W. F., et al. (2023) · The Journal of Immunology · doi:10.4049/jimmunol.2300293 · Cited by 27
Hypoxia-inducible factor-1: A possible link between inhalational anesthetics and tumor progression?
Zhao, H., Iwasaki, M., Yang, J., Savage, S., & Ma, D. (2014) · Acta anaesthesiologica Taiwanica · doi:10.1016/j.aat.2014.05.008 · Cited by 28
Igwe, E. I., Essler, S., Al-Furoukh, N., Dehne, N., & Brüne, B. (2009) · BMC Genomics · doi:10.1186/1471-2164-10-408 · Cited by 27
Chen, Y., Comeaux, L. M., Herbst, R. W., Saban, E., Kennedy, D. C., Maroney, M. J., & Knapp, M. J. (2008) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2008.07.018 · Cited by 28
RETRACTED: Siah-1 facilitates ubiquitination and degradation of factor inhibiting HIF-1α (FIH)
Fukuba, H., Yamashita, H., Nagano, Y., Jin, H. G., Hiji, M., Ohtsuki, T., Takahashi, T., Kohriyama, T., & Matsumoto, M. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.12.051 · Cited by 27
RetractedHIF gene expression in cancer therapy
Chan, D. A., Krieg, A. J., Turcotte, S., & Giaccia, A. J. (2007) · Methods in Enzymology · doi:10.1016/s0076-6879(07)35016-7 · Cited by 26
Hypoxia-inducible factor: roles in development, physiology, and disease
Chandel, N. S., & Simon, M. C. (2008) · Cell Death & Differentiation · doi:10.1038/cdd.2008.11 · Cited by 26
Regulation of the HIF switch in human endothelial and cancer cells
Slawski, J., Jaśkiewicz, M., Barton, A., Kozioł, S., Collawn, J. F., & Bartoszewski, R. (2024) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2024.151386 · Cited by 26
Nsiah, N. Y., Morgan, A. B., Donkor, N., & Inman, D. M. (2023) · Scientific Reports · doi:10.1038/s41598-023-47942-8 · Cited by 27
So, J.-H., Kim, J., Yoo, K.-W., Kim, H.-T., Jung, S.-H., Choi, J.-H., Lee, M., Jin, S., & Kim, C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0109517 · Cited by 27
55th Bowditch Lecture: Effects of chronic hypoxia on the pulmonary circulation: Role of HIF-1
Shimoda, L. A. (2012) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00843.2012 · Cited by 28
Cyclosporin a induces renal episodic hypoxia
Fähling, M., Mathia, S., Scheidl, J., Abramovitch, R., Milman, Z., Paliege, A., Peters, H., Persson, P. B., Heyman, S. N., & Rosenberger, C. (2016) · Acta Physiologica · doi:10.1111/apha.12811 · Cited by 26
An overview of biological research on hypoxia-inducible factors (HIFs)
Liu, Z., Wu, Z., Fan, Y., & Fang, Y. (2020) · Endokrynologia Polska · doi:10.5603/ep.a2020.0064 · Cited by 26
Cattaneo, M. G., Cappellini, E., Benfante, R., Ragni, M., Omodeo‐Salè, F., Nisoli, E., Borgese, N., & Vicentini, L. M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0029680 · Cited by 26
The intravenous anesthetics barbiturates inhibit hypoxia-inducible factor 1 activation
Wakamatsu, T., Tanaka, T., Oda, S., Nishi, K., Harada, H., Daijo, H., Takabuchi, S., Kai, S., Fukuda, K., & Hirota, K. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.06.060 · Cited by 26
Self-citationYeom, C. J., Zeng, L., Zhu, Y., Hiraoka, M., & Harada, H. (2011) · Cancers · doi:10.3390/cancers3033610 · Cited by 26
Hypoxia-Inducible Factor-1 Alpha in the Heart
Hashmi, S., & Al‐Salam, S. (2012) · Cardiology in Review · doi:10.1097/crd.0b013e31826287f6 · Cited by 26
Cellular adaptation to oxygen deficiency beyond the Nobel award
López‐Barneo, J., & Simon, M. C. (2020) · Nature Communications · doi:10.1038/s41467-020-14469-9 · Cited by 26
Balamurugan, K., Luu, V.-D., Kaufmann, M., Hofmann, V. S., Boysen, G., Barth, S., Bordoli, M. R., Stiehl, D. P., Moch, H., Schraml, P., et al. (2009) · Oncogene · doi:10.1038/onc.2009.186 · Cited by 26
HIF inhibitors for ischemic retinopathies and cancers: options beyond anti-VEGF therapies
Subhani, S., Vavilala, D. T., & Mukherji, M. (2016) · Angiogenesis · doi:10.1007/s10456-016-9510-0 · Cited by 27
Perkins, E. J., Woolard, A., & García‐Reyero, N. (2022) · Frontiers in Toxicology · doi:10.3389/ftox.2022.786057 · Cited by 25
Epigenetic modulators mitigate angiogenesis through a complex transcriptomic network
Shankar, T. V. S., & Willems, L. (2014) · Vascular Pharmacology · doi:10.1016/j.vph.2014.01.003 · Cited by 25
HIF-1α induces MXI1 by alternate promoter usage in human neuroblastoma cells
Löfstedt, T., Fredlund, E., Noguera, R., Navarro, S., Mengelbier, L. H., Beckman, S., Påhlman, S., & Axelson, H. (2009) · Experimental Cell Research · doi:10.1016/j.yexcr.2009.02.015 · Cited by 25
Kimura, M., Takabuchi, S., Tanaka, T., Murata, M., Nishi, K., Oda, S., Oda, T., Kanai, M., Fukuda, K., Kizaka‐Kondoh, S., et al. (2008) · Biochemical Journal · doi:10.1042/bj20070824 · Cited by 25
Self-citationHurst, J. H. (2016) · Journal of Clinical Investigation · doi:10.1172/jci90055 · Cited by 27
Martin, A. R., Ronco, C., Demange, L., & Benhida, R. (2016) · MedChemComm · doi:10.1039/c6md00432f · Cited by 27
Manresa, M. C., Smith, L., Casals‐Diaz, L., Fagundes, R. R., Brown, E., Radhakrishnan, P., Murphy, S. J., Crifò, B., Strowitzki, M. J., Halligan, D. N., et al. (2018) · Allergy · doi:10.1111/all.13655 · Cited by 25
Diabetic atherosclerosis: is there a role for the hypoxia-inducible factors?
Pirri, D., Fragiadaki, M., & Evans, P. C. (2020) · Bioscience Reports · doi:10.1042/bsr20200026 · Cited by 26
Giatromanolaki, A. N., Koukourakis, M. I., Pezzella, F., Turley, H., Sivridis, E., Bouros, D. E., Bougioukas, G., Harris, A. L., & Gatter, K. C. (2008) · Cancer Letters · doi:10.1016/j.canlet.2007.11.041 · Cited by 27
Zaarour, R. F., Ribeiro, M., Azzarone, B. G., Kapoor, S., & Chouaı̈b, S. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1222575 · Cited by 25
Crake, R., Burgess, E. R., Royds, J. A., Phillips, E., Vissers, M. C. M., & Dachs, G. U. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.619300 · Cited by 24
Targeting the molecular effects of a hypoxic tumor microenvironment
Cárdenas-Navia, L. I. (2007) · Frontiers in bioscience · doi:10.2741/2372 · Cited by 24
Singleton, R. S., Trudgian, D. C., Fischer, R., Kessler, B. M., Ratcliffe, P. J., & Cockman, M. E. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.262808 · Cited by 25
Baek, J. H., Reiter, C. E. N., Manalo, D. J., Buehler, P. W., Hider, R. C., & Alayash, A. I. (2011) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2011.04.010 · Cited by 24
Liu, Y., Higashitsuji, H., Higashitsuji, H., Itoh, K., Sakurai, T., Koike, K., Hirota, K., Fukumoto, M., & Fujita, J. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.01.093 · Cited by 24
Self-citationHypoxia. Hypoxia, hypoxia inducible factor and myeloid cell function
Walmsley, S. R., Chilvers, E. R., & Whyte, M. K. B. (2009) · Arthritis Research & Therapy · doi:10.1186/ar2632 · Cited by 24
Metabolic Phenotyping of Anks3 Depletion in mIMCD-3 cells - a Putative Nephronophthisis Candidate
Schlimpert, M., Lagies, S., Budnyk, V., Müller, B., Walz, G., & Kammerer, B. (2018) · Scientific Reports · doi:10.1038/s41598-018-27389-y · Cited by 26
Fuse, S., Suzuki, K., Kuchimaru, T., Kadonosono, T., Ueda, H., Sato, S., Kizaka‐Kondoh, S., & Nakamura, H. (2019) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2019.115207 · Cited by 24
Pan, S., Chiang, W., & Chen, Y. (2020) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2020.06.006 · Cited by 24
Engineering vascularized tissues using natural and synthetic small molecules
Sefcik, L. S., Aronin, C. E. P., & Botchwey, E. A. (2008) · Organogenesis · doi:10.4161/org.4.4.6963 · Cited by 24
Milenković, D., Rodriguez‐Mateos, A., Lucosz, M., Istas, G., Declerck, K., Sansone, R., Deenen, R., Köhrer, K., Corral‐Jara, K. F., Altschmied, J., et al. (2022) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202100991 · Cited by 23
Focusing on the hypoxia-inducible factor pathway: role, regulation, and therapy for osteoarthritis
Guo, H., Huang, J., Liang, Y., Wang, D., & Zhang, H. (2022) · European journal of medical research · doi:10.1186/s40001-022-00926-2 · Cited by 23
Environmental and behavioral regulation of HIF-mitochondria crosstalk
Burtscher, J., Hohenauer, E., Burtscher, M., Millet, G. P., & Egg, M. (2023) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2023.06.015 · Cited by 27
Oda, S., Oda, T., Takabuchi, S., Nishi, K., Wakamatsu, T., Tanaka, T., Adachi, T., Fukuda, K., Nohara, R., & Hirota, K. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.01.012 · Cited by 23
Self-citationWang, P., Zhang, X., Liu, F., & Wang, W. (2025) · Research · doi:10.34133/research.0651 · Cited by 23
Kim, I., Shin, S.-H., Lee, J. E., & Park, J. (2019) · Oncogene · doi:10.1038/s41388-019-0676-y · Cited by 22
Hypoxia-inducible factors not only regulate but also are myeloid-cell treatment targets
Kling, L., Schreiber, A., Eckardt, K., & Kettritz, R. (2020) · Journal of Leukocyte Biology · doi:10.1002/jlb.4ri0820-535r · Cited by 25
Footprints of microRNAs in Cancer Biology
Rajasegaran, Y., Azlan, A., Rosli, A. A., Yik, M. Y., Khor, K. Z., Yusoff, N. M., & Moses, E. J. (2021) · Biomedicines · doi:10.3390/biomedicines9101494 · Cited by 22
Functional crosstalk between chromatin and hypoxia signalling
Collier, H., Albanese, A., Kwok, C.-S., Kou, J., & Rocha, S. (2023) · Cellular Signalling · doi:10.1016/j.cellsig.2023.110660 · Cited by 23
Jawad, S. F., Altalbawy, F. M. A., Hussein, R. M., Fadhil, A. A., Jawad, M. A., Zabibah, R. S., Taraki, T. Y., Mohan, C. D., & Rangappa, K. S. (2023) · Cancer and Metastasis Reviews · doi:10.1007/s10555-023-10129-8 · Cited by 24
HIF-1α: A potential therapeutic opportunity in renal fibrosis
Liu, D., Wang, L., Ha, W., Li, K., Shen, R., & Wang, D. (2023) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2023.110808 · Cited by 26
Cong, X., Li, X., Xu, K., Yin, L., Liang, G., Sun, R., Pu, Y., & Zhang, J. (2024) · Environment International · doi:10.1016/j.envint.2024.108493 · Cited by 22
Induction of the von Hippel‐Lindau tumor suppressor gene by late hypoxia limits HIF‐1 expression
Karhausen, J., Kong, T., Narravula, S., & Colgan, S. P. (2005) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20489 · Cited by 23
Hara, T., Mimura, K., Seiki, M., & Sakamoto, T. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.08.085 · Cited by 23
Mouse Fem1b interacts with and induces ubiquitin-mediated degradation of Ankrd37
Shi, Y.-Q., Liao, S.-Y., Zhuang, X.-J., & Han, C. (2011) · Gene · doi:10.1016/j.gene.2011.06.025 · Cited by 22
Metabolic sensors and their interplay with cell signalling and transcription
Krejčı́, A. (2012) · Biochemical Society Transactions · doi:10.1042/bst20110767 · Cited by 23
Specific inhibition of HIF activity: can peptides lead the way?
Mylonis, I., Chachami, G., & Simos, G. (2021) · Cancers · doi:10.3390/cancers13030410 · Cited by 21
Metadata
- Authors
- Mahon, P. C., Hirota, K., & Semenza, G. L.
- Affiliations
- Johns Hopkins University (US)
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2001-10-15
- Volume
- 15
- Issue
- 20
- Pages
- 2675-2686
- ISSN
- 0890-9369 (ISSN-L)
- 1549-5477
- PMC
- PMC312814
- OpenAlex
- W2089692551
- Semantic Scholar
- 76cac1c7209112ecf9989f7cc81e563b7881292c
- Cited by
- 1,385
- References
- 47
- Citations by year
- 2026: 23 · 2025: 31 · 2024: 40 · 2023: 52 · 2022: 63 · 2021: 71 · 2020: 58 · 2019: 64 · 2018: 47 · 2017: 50 · 2016: 61 · 2015: 60 · 2014: 54 · 2013: 56 · 2012: 59
- Type
- posted content
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Genes & Development (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Uehara Memorial Foundation
- National Institutes of Health (5r01dk039869-16)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01 DK39869)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Kruppel-like factors research
- Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
- Keywords
- FIH-1, HIF-1α, VHL, HIF-1, transcriptional repression, histone deacetylase, corepressors, oxygen sensing, protein-protein interaction, ubiquitination, proteasomal degradation, oxygen homeostasis
- MeSH terms
- Amino Acid Sequence, Animals, Cells, Cultured, DNA-Binding Proteins, Fungal Proteins, Gene Expression Regulation, Glutathione Transferase, Histone Deacetylases, Humans, Mixed Function Oxygenases, Ligases, Luciferases, Molecular Sequence Data, Nuclear Proteins, Oxygen, Protein Conformation, Rabbits, Repressor Proteins, Reticulocytes, Saccharomyces cerevisiae, Transcription Factors, Transcription, Genetic, Signal Transduction, Transcriptional Activation, Cell Hypoxia, Polymerase Chain Reaction, Sequence Homology, Amino Acid, DNA Primers, Two-Hybrid System Techniques, Tumor Suppressor Proteins, Saccharomyces cerevisiae Proteins, Ubiquitin-Protein Ligases, Von Hippel-Lindau Tumor Suppressor Protein, Hypoxia-Inducible Factor 1, alpha Subunit, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
